[ad_1]
“I am pleased to announce that the Oxford-AstraZeneca vaccines were developed here in the UK [kūrėjai] submitted the completed data pack for approval by the MHRA [Vaistų ir sveikatos priežiūros priemonių priežiūros agentūra]”He said at a press conference.
“This is one more step toward a solution for vaccine distribution,” Hancock added.
During the same press conference, the Health Secretary announced that Britain would restrict air travel with South Africa to stop the spread of another new, probably more contagious strain of coronavirus.
The UK had already authorized the distribution of the COVID-19 vaccine, developed by the German company BioNTech and the US pharmaceutical giant Pfizer, earlier this month. About half a million people in the country have already been vaccinated against the disease, who are at the highest risk.
The majority of the UK population is expected to be vaccinated with AstraZeneca and the University of Oxford, a government that ordered 100 million. dose.
[ad_2]
